JamesScottRobertsonMD

PubMed

• The prevalence and risk factors of dental disease found in 100 miniature horses.
  Tinsley, T., Fogle, C., Means, E., Robertston, J.> ;Frontiers in Veterinary Science. 2023 Jan 1
• Challenges and successes for the grantees and the Technical Advisory Group of WHO's influenza vaccine technology transfer initiative.
  Grohmann G, Francis DP, Sokhey J, Robertson J> ;Vaccine. 2016-10-26
• The Ability of a Non-Egg Adapted (Cell-Like) A(H1N1)pdm09 Virus to Egg-Adapt at HA Loci Other than 222 and 223 and Its Effect on the Yield of Viral Protein.
  Nicolson C, Harvey R, Engelhardt OG, Robertson JS> ;PLoS ONE. 2016-01-01
• Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment.
  Monath TP, Seligman SJ, Robertson JS, Guy B, Hayes EB, Condit RC, Excler JL, Mac LM, Carbery B, Chen RT> ;Vaccine. 2015-01-01
• The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).
  Chen RT, Carbery B, Mac L, Berns KI, Chapman L, Condit RC, Excler J, Gurwith M, Hendry M, Khan AS, Khuri-Bulos N, Klug B, Robertson JS, Seligman SJ, Sheets R, Williams...> ;Vaccine. 2015-01-01
• Assessing PreCR™ repair enzymes for restoration of STR profiles from artificially degraded DNA for human identification.
  Robertson, J. M.,Dineen, S. M.,Scott, K. A.,Lucyshyn, J.,Saeed, M.,Murphy, D. L.,Schweighardt, A. J.,Meiklejohn, K. A.> ;Forensic Sci Int Genet. 2014 Jul 06
• Determination of an Effective Housekeeping Gene for the Quantification of mRNA for Forensic Applications*
  Moreno, L.I., Tate, C.M., Knott, E.L., McDaniel, J.E., Rogers, S.S., Koons, B.W., Kavlick, M.F., Craig, R.L., Robertson, J.M.> ;J Forensic Sci. 2012 Jul
• Application of deglycosylation to SDS PAGE analysis improves calibration of influenza antigen standards.
  Harvey, R.,Hamill, M.,Robertson, J. S.,Minor, P. D.,Vodeiko, G. M.,Weir, J. P.,Takahashi, H.,Harada, Y.,Itamura, S.,Bamford, P.,Dalla Pozza, T.,Engelhardt, O. G.> ;Biologicals. 2012 Jan
• An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs.
  Nicolson, C., Harvey, R., Johnson, R., Guilfoyle, K., Engelhardt, O.G., Robertson, J.S.> ;Vaccine. 2012 Jan 17
• Evaluation of mRNA marker specificity for the identification of five human body fluids by capillary electrophoresis.
  Richard, M.L., Harper, K.A., Craig, R.L., Onorato, A.J., Robertson, J.M., Donfack, J.> ;Forensic Sci Int Genet. 2012 Jul
• Prospects for controlling future pandemics of influenza.
  Robertson, J.S., Inglis, S.C.> ;Virus Res. 2011 Dec
• Quantification of Human Mitochondrial DNA Using Synthesized DNA Standards*
  Kavlick, M.F., Lawrence, H.S., Merritt, R.T., Fisher, C., Isenberg, A., Robertson, J.M., Budowle, B.> ;J Forensic Sci. 2011 Nov
• Evaluation of circular DNA substrates for whole genome amplification prior to forensic analysis.
  Tate, C. M., Nuñez, A. N., Goldstein, C. A., Gomes, I., Robertson, J. M., Kavlick, M. F., Budowle, B.> ;Forensic Sci Int Genet. 2012 Mar
• Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric haemagglutinin molecules.
  Harvey, R., Guilfoyle, K.A., Roseby, S., Robertson, J.S., Engelhardt, O.G.> ;J Virol. 2011 Jun
• Use of fatty acid methyl ester profiles for discrimination of Bacillus cereus T-strain spores grown on different media.
  Ehrhardt, C.J., Chu, V., Brown, T., Simmons, T.L., Swan, B.K., Bannan, J., Robertson, J.M.> ;Appl Environ Microbiol. 2010 Mar
• Comparison and evaluation of RNA quantification methods using viral, prokaryotic, and eukaryotic RNA over a 10(4) concentration range.
  Aranda, R., Dineen, S.M., Craig, R.L., Guerrieri, R.A., Robertson, J.M.> ;Anal Biochem. 2009-04-01
• Coadministration of propofol and remifentanil for lumbar puncture in children: dose-response and an evaluation of two dose combinations.
  Hayes, J.A., Lopez, A.V., Pehora, C.M., Robertson, J.M., Abla, O., Crawford, M.W.> ;Anesthesiology. 2008-10-01
• Recovery efficiencies of anthrax spores and ricin from nonporous or nonabsorbent and porous or absorbent surfaces by a variety of sampling methods*.
  Frawley, D.A., Samaan, M.N., Bull, R.L., Robertson, J.M., Mateczun, A.J., Turnbull, P.B.> ;J Forensic Sci. 2008 Sep
• Changes in biological source material.
  Robertson JS> ;Biologicals. 2006-03-01
• Assuring the quality, safety, and efficacy of DNA vaccines.
  Robertson, J.S., Griffiths, E.> ;Methods Mol Med. 2006
• Preparation of vaccines against H5N1 influenza.
  Wood JM, Major D, Newman RW, Dunleavy U, Nicolson C, Robertson JS, Schild GC> ;Vaccine. 2002-05-15
• Vaccines against H5N1 influenza.
  Wood JM, Major D, Daly J, Newman RW, Dunleavy U, Nicolson C, Robertson JS, Schild GC, Lee-Lin YN> ;Vaccine. 1999-11-12
• Summary and conclusion. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals.
  Castle P, Robertson JS> ;Dev. Biol. Stand.. 1999-01-01
• Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals. 5-6 May 1998, Strasbourg, France.
  Castle P, Robertson JS> ;Biologicals. 1998-12-01
• Direct sequencing of the HA gene of clinical equine H3N8 influenza virus and comparison with laboratory derived viruses.
  Ilobi CP, Nicolson C, Taylor J, Mumford JA, Wood JM, Robertson JS> ;Arch. Virol.. 1998-01-01
• Join now to see all